Polygenic contributions to alcohol use and alcohol use disorders across population-based and clinically ascertained samples.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 21 1 2020
medline: 1 12 2021
entrez: 21 1 2020
Statut: ppublish

Résumé

Studies suggest that alcohol consumption and alcohol use disorders have distinct genetic backgrounds. We examined whether polygenic risk scores (PRS) for consumption and problem subscales of the Alcohol Use Disorders Identification Test (AUDIT-C, AUDIT-P) in the UK Biobank (UKB; N = 121 630) correlate with alcohol outcomes in four independent samples: an ascertained cohort, the Collaborative Study on the Genetics of Alcoholism (COGA; N = 6850), and population-based cohorts: Avon Longitudinal Study of Parents and Children (ALSPAC; N = 5911), Generation Scotland (GS; N = 17 461), and an independent subset of UKB (N = 245 947). Regression models and survival analyses tested whether the PRS were associated with the alcohol-related outcomes. In COGA, AUDIT-P PRS was associated with alcohol dependence, AUD symptom count, maximum drinks (R2 = 0.47-0.68%, p = 2.0 × 10-8-1.0 × 10-10), and increased likelihood of onset of alcohol dependence (hazard ratio = 1.15, p = 4.7 × 10-8); AUDIT-C PRS was not an independent predictor of any phenotype. In ALSPAC, the AUDIT-C PRS was associated with alcohol dependence (R2 = 0.96%, p = 4.8 × 10-6). In GS, AUDIT-C PRS was a better predictor of weekly alcohol use (R2 = 0.27%, p = 5.5 × 10-11), while AUDIT-P PRS was more associated with problem drinking (R2 = 0.40%, p = 9.0 × 10-7). Lastly, AUDIT-P PRS was associated with ICD-based alcohol-related disorders in the UKB subset (R2 = 0.18%, p < 2.0 × 10-16). AUDIT-P PRS was associated with a range of alcohol-related phenotypes across population-based and ascertained cohorts, while AUDIT-C PRS showed less utility in the ascertained cohort. We show that AUDIT-P is genetically correlated with both use and misuse and demonstrate the influence of ascertainment schemes on PRS analyses.

Sections du résumé

BACKGROUND
Studies suggest that alcohol consumption and alcohol use disorders have distinct genetic backgrounds.
METHODS
We examined whether polygenic risk scores (PRS) for consumption and problem subscales of the Alcohol Use Disorders Identification Test (AUDIT-C, AUDIT-P) in the UK Biobank (UKB; N = 121 630) correlate with alcohol outcomes in four independent samples: an ascertained cohort, the Collaborative Study on the Genetics of Alcoholism (COGA; N = 6850), and population-based cohorts: Avon Longitudinal Study of Parents and Children (ALSPAC; N = 5911), Generation Scotland (GS; N = 17 461), and an independent subset of UKB (N = 245 947). Regression models and survival analyses tested whether the PRS were associated with the alcohol-related outcomes.
RESULTS
In COGA, AUDIT-P PRS was associated with alcohol dependence, AUD symptom count, maximum drinks (R2 = 0.47-0.68%, p = 2.0 × 10-8-1.0 × 10-10), and increased likelihood of onset of alcohol dependence (hazard ratio = 1.15, p = 4.7 × 10-8); AUDIT-C PRS was not an independent predictor of any phenotype. In ALSPAC, the AUDIT-C PRS was associated with alcohol dependence (R2 = 0.96%, p = 4.8 × 10-6). In GS, AUDIT-C PRS was a better predictor of weekly alcohol use (R2 = 0.27%, p = 5.5 × 10-11), while AUDIT-P PRS was more associated with problem drinking (R2 = 0.40%, p = 9.0 × 10-7). Lastly, AUDIT-P PRS was associated with ICD-based alcohol-related disorders in the UKB subset (R2 = 0.18%, p < 2.0 × 10-16).
CONCLUSIONS
AUDIT-P PRS was associated with a range of alcohol-related phenotypes across population-based and ascertained cohorts, while AUDIT-C PRS showed less utility in the ascertained cohort. We show that AUDIT-P is genetically correlated with both use and misuse and demonstrate the influence of ascertainment schemes on PRS analyses.

Identifiants

pubmed: 31955720
doi: 10.1017/S0033291719004045
pii: S0033291719004045
pmc: PMC7405725
mid: NIHMS1614112
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1147-1156

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : K02 DA032573
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : K01 DA037914
Pays : United States
Organisme : Medical Research Council
ID : G0700704
Pays : United Kingdom
Organisme : NIAAA NIH HHS
ID : K01 AA021399
Pays : United States
Organisme : Medical Research Council
ID : MR/L022206/1
Pays : United Kingdom
Organisme : NIAAA NIH HHS
ID : P50 AA022537
Pays : United States
Organisme : NIAAA NIH HHS
ID : K02 AA018755
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00007/10
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0802736
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : NIAAA NIH HHS
ID : U10 AA008401
Pays : United States
Organisme : Medical Research Council
ID : G0800612
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_12028
Pays : United Kingdom
Organisme : NIAAA NIH HHS
ID : R01 AA018333
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K026992/1
Pays : United Kingdom

Références

Alcohol Health Res World. 1995;19(3):228-236
pubmed: 31798102
Alcohol Clin Exp Res. 2011 Dec;35(12):2152-61
pubmed: 21689117
Addict Biol. 2016 Mar;21(2):469-80
pubmed: 25865819
Alcohol Clin Exp Res. 2018 Mar;42(3):520-530
pubmed: 29405378
Soc Sci Med. 2018 Jul;209:51-58
pubmed: 29793164
Psychol Med. 2011 Jul;41(7):1507-16
pubmed: 20942993
BJPsych Open. 2018 Apr 03;4(3):83-90
pubmed: 29971151
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Alcohol Clin Exp Res. 2017 Feb;41(2):359-368
pubmed: 28073157
Alcohol Clin Exp Res. 2013 Aug;37(8):1424-31
pubmed: 23458300
J Stud Alcohol. 1994 Mar;55(2):149-58
pubmed: 8189735
Nat Genet. 2019 Feb;51(2):237-244
pubmed: 30643251
Alcohol Clin Exp Res. 2019 Jun;43(6):1113-1125
pubmed: 30994927
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Ann N Y Acad Sci. 2006 Dec;1094:193-201
pubmed: 17347351
Nat Commun. 2019 Apr 2;10(1):1499
pubmed: 30940813
Alcohol Clin Exp Res. 2018 Sep;42(9):1704-1714
pubmed: 29975427
Addiction. 2015 Feb;110(2):269-78
pubmed: 25251778
JAMA. 1992 Oct 14;268(14):1877-82
pubmed: 1404711
Elife. 2019 Mar 21;8:
pubmed: 30895923
Addict Biol. 2019 Jan;24(1):121-131
pubmed: 29058377
JAMA. 1984 Oct 12;252(14):1905-7
pubmed: 6471323
Bioinformatics. 2015 May 1;31(9):1466-8
pubmed: 25550326
Int J Epidemiol. 2013 Jun;42(3):689-700
pubmed: 22786799
Nat Neurosci. 2018 Dec;21(12):1656-1669
pubmed: 30482948
Mol Psychiatry. 2017 Oct;22(10):1376-1384
pubmed: 28937693
Alcohol Clin Exp Res. 2017 Jan;41(1):57-64
pubmed: 27892595
Drug Alcohol Depend. 2018 Feb 1;183:7-12
pubmed: 29220643
Int J Epidemiol. 2020 Apr 1;49(2):410-421
pubmed: 31263887
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Arch Gen Psychiatry. 2004 Dec;61(12):1246-56
pubmed: 15583116
Am J Hum Genet. 2017 Apr 6;100(4):635-649
pubmed: 28366442
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14372-14377
pubmed: 27911795
BMJ Open. 2013 Aug 19;3(8):e003015
pubmed: 23959750
Int J Epidemiol. 2018 Feb 1;47(1):13-14g
pubmed: 29040551
Am J Hum Genet. 2004 Apr;74(4):765-9
pubmed: 14997420
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Psychol Med. 2012 Nov;42(11):2421-31
pubmed: 22423619
Psychol Med. 2020 Feb;50(3):484-498
pubmed: 30874500
Am J Psychiatry. 2019 Feb 1;176(2):107-118
pubmed: 30336701
Psychol Addict Behav. 2000 Sep;14(3):303-7
pubmed: 10998957
Genet Epidemiol. 2012 Apr;36(3):214-24
pubmed: 22714935
Behav Genet. 2006 Jul;36(4):483-97
pubmed: 16586152

Auteurs

Emma C Johnson (EC)

Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.

Sandra Sanchez-Roige (S)

Department of Psychiatry, University of California San Diego, San Diego, CA, USA.

Laura Acion (L)

Department of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, IA, USA.

Mark J Adams (MJ)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Kathleen K Bucholz (KK)

Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.

Grace Chan (G)

Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, USA.

Michael J Chao (MJ)

Department of Neuroscience, Icahn School of Medicine at Mt. Sinai, New York, NY, USA.

David B Chorlian (DB)

Department of Psychiatry, Suny Downstate Medical Center, Brooklyn, NY, USA.

Danielle M Dick (DM)

Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.
Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA.

Howard J Edenberg (HJ)

Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.

Tatiana Foroud (T)

Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.

Caroline Hayward (C)

MRC Human Genetics Unit, University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, UK.

Jon Heron (J)

University of Bristol, Bristol Medical School, Population Health Sciences, Bristol, UK.

Victor Hesselbrock (V)

Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, USA.

Matthew Hickman (M)

University of Bristol, Bristol Medical School, Population Health Sciences, Bristol, UK.

Kenneth S Kendler (KS)

Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Sivan Kinreich (S)

Department of Psychiatry, Suny Downstate Medical Center, Brooklyn, NY, USA.

John Kramer (J)

Department of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, IA, USA.

Sally I-Chun Kuo (SI)

Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.

Samuel Kuperman (S)

Department of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, IA, USA.

Dongbing Lai (D)

Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.

Andrew M McIntosh (AM)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Jacquelyn L Meyers (JL)

Department of Psychiatry, Suny Downstate Medical Center, Brooklyn, NY, USA.

Martin H Plawecki (MH)

Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA.

Bernice Porjesz (B)

Department of Psychiatry, Suny Downstate Medical Center, Brooklyn, NY, USA.

David Porteous (D)

University of Edinburgh, Institute of Genetics & Molecular Medicine, Centre for Genomic and Experimental Medicine, Edinburgh, UK.

Marc A Schuckit (MA)

Department of Psychiatry, University of California San Diego, San Diego, CA, USA.

Jinni Su (J)

Department of Psychology, Arizona State University, Tempe, AZ, USA.

Yong Zang (Y)

Department of Biostatistics, Indiana University School of Medicine, Bloomington, IN, USA.

Abraham A Palmer (AA)

Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
University of California San Diego, Institute for Genomic Medicine, San Diego, CA, USA.

Arpana Agrawal (A)

Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.

Toni-Kim Clarke (TK)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Alexis C Edwards (AC)

Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH